Rapid Novor Inc is a leading proteomics Contract Research Organization (CRO) that offers a wide range of services for protein analysis, protein interaction, and discovery through mass spectrometry. With their advanced technology and expertise, they empower biotech and pharmaceutical companies to unlock the full potential of antibodies and drive breakthroughs in the field of life sciences. Their services include Antibody Sequencing, Protein Sequencing, Antibody Discovery, HDX-MS, Epitope Mapping, Surface Plasmon Resonance, Peptide Mapping & Analysis, Antibody Expression, Immune Response Profiling, Glycan Analysis, and more.

By providing precise and efficient sequencing solutions, Rapid Novor supports researchers in understanding proteins better and sooner in their discovery process, reducing risk, increasing success probabilities, and accelerating antibody discovery. With over 21 years of proteomics innovation, Rapid Novor has successfully completed 8000+ sequencing projects and served more than 430 clients. Their commitment to excellence and their cutting-edge technology make them the go-to solution for researchers and companies looking to decode immunity and drive breakthroughs in life sciences